Drug class
Acetylated L-leucine; neurometabolic therapy for selected inherited neurological disorders
Mechanism of action
The mechanism is not fully established. Acetylated leucine may modulate neuronal energy metabolism, membrane stability and cerebellar network function; no single molecular target is confirmed as the clinical mechanism.
General use cases
- Treatment of neurological manifestations of Niemann-Pick disease type C (NPC) in adults and paediatric patients weighing at least 15 kg under the US AQNEURSA indication
- Treatment of ataxia-telangiectasia in adults and paediatric patients weighing at least 15 kg under the US indication where authorised; verify current label wording for disease-specific use
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
